Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 598

1.

MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.

Zhao G, Cai C, Yang T, Qiu X, Liao B, Li W, Ji Z, Zhao J, Zhao H, Guo M, Ma Q, Xiao C, Fan Q, Ma B.

PLoS One. 2013;8(1):e53906. doi: 10.1371/journal.pone.0053906. Epub 2013 Jan 23. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/f47e2af6-da90-40ee-871c-f9ed6f58a48c.

PMID:
23372675
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.

Li G, Cai M, Fu D, Chen K, Sun M, Cai Z, Cheng B.

Cell Physiol Biochem. 2012;30(6):1481-90. doi: 10.1159/000343336. Epub 2012 Dec 7.

PMID:
23208072
[PubMed - indexed for MEDLINE]
3.

MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.

Xiong B, Cheng Y, Ma L, Zhang C.

Int J Oncol. 2013 Jan;42(1):219-28. doi: 10.3892/ijo.2012.1707. Epub 2012 Nov 20.

PMID:
23174819
[PubMed - indexed for MEDLINE]
4.

miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.

Yang SM, Huang C, Li XF, Yu MZ, He Y, Li J.

Toxicology. 2013 Apr 5;306:162-8. doi: 10.1016/j.tox.2013.02.014. Epub 2013 Mar 4.

PMID:
23466500
[PubMed - indexed for MEDLINE]
5.

Klotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathway.

Wang Y, Chen L, Huang G, He D, He J, Xu W, Zou C, Zong F, Li Y, Chen B, Wu S, Zhao W, Wu J.

PLoS One. 2013;8(2):e57391. doi: 10.1371/journal.pone.0057391. Epub 2013 Feb 21.

PMID:
23437382
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.

Wu Z, He B, He J, Mao X.

Prostate. 2013 May;73(6):596-604. doi: 10.1002/pros.22600. Epub 2012 Oct 11.

PMID:
23060044
[PubMed - indexed for MEDLINE]
7.

MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.

Liu ZL, Wang H, Liu J, Wang ZX.

Mol Cell Biochem. 2013 Jan;372(1-2):35-45. doi: 10.1007/s11010-012-1443-3. Epub 2012 Sep 6.

PMID:
22956424
[PubMed - indexed for MEDLINE]
8.

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.

Zhou Y, Huang Z, Wu S, Zang X, Liu M, Shi J.

J Exp Clin Cancer Res. 2014 Jan 27;33:12. doi: 10.1186/1756-9966-33-12.

PMID:
24468065
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.

Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ.

Cancer Res. 2008 Jan 15;68(2):425-33. doi: 10.1158/0008-5472.CAN-07-2488. Erratum in: Cancer Res. 2008 Mar 1;68(5):1609.

PMID:
18199536
[PubMed - indexed for MEDLINE]
Free Article
10.

LY294002 induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like cells from human osteosarcoma via down-regulation of PI3K activity.

Gong C, Liao H, Wang J, Lin Y, Qi J, Qin L, Tian LQ, Guo FJ.

Asian Pac J Cancer Prev. 2012;13(7):3103-7.

PMID:
22994717
[PubMed - indexed for MEDLINE]
Free Article
11.

Downregulated microRNA-32 expression induced by high glucose inhibits cell cycle progression via PTEN upregulation and Akt inactivation in bone marrow-derived mesenchymal stem cells.

Zhu G, Chai J, Ma L, Duan H, Zhang H.

Biochem Biophys Res Commun. 2013 Apr 19;433(4):526-31. doi: 10.1016/j.bbrc.2013.03.018. Epub 2013 Mar 21.

PMID:
23524257
[PubMed - indexed for MEDLINE]
12.

Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells.

Fu X, Tian J, Zhang L, Chen Y, Hao Q.

FEBS Lett. 2012 May 7;586(9):1279-86. doi: 10.1016/j.febslet.2012.03.006. Epub 2012 Mar 27.

PMID:
22465665
[PubMed - indexed for MEDLINE]
Free Article
13.

miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.

Cao W, Yang W, Fan R, Li H, Jiang J, Geng M, Jin Y, Wu Y.

Tumour Biol. 2014 Feb;35(2):1287-95. doi: 10.1007/s13277-013-1171-7. Epub 2013 Sep 26.

PMID:
24068565
[PubMed - indexed for MEDLINE]
14.

Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma.

Wu Z, Min L, Chen D, Hao D, Duan Y, Qiu G, Wang Y.

PLoS One. 2011 Feb 2;6(2):e14648. doi: 10.1371/journal.pone.0014648.

PMID:
21311599
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.

Cai CK, Zhao GY, Tian LY, Liu L, Yan K, Ma YL, Ji ZW, Li XX, Han K, Gao J, Qiu XC, Fan QY, Yang TT, Ma BA.

Oncol Rep. 2012 Nov;28(5):1764-70. doi: 10.3892/or.2012.1995. Epub 2012 Aug 24.

PMID:
22922827
[PubMed - indexed for MEDLINE]
16.

Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling.

Wang K, Zhuang Y, Liu C, Li Y.

Arch Biochem Biophys. 2012 Oct 1;526(1):38-43. doi: 10.1016/j.abb.2012.07.003. Epub 2012 Jul 20.

PMID:
22820099
[PubMed - indexed for MEDLINE]
17.

MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN.

Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z, Chun-Sheng K.

BMC Cancer. 2010 Jul 12;10:367. doi: 10.1186/1471-2407-10-367.

PMID:
20618998
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.

Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, Fu L.

Carcinogenesis. 2013 Feb;34(2):454-63. doi: 10.1093/carcin/bgs346. Epub 2012 Nov 3.

PMID:
23125220
[PubMed - indexed for MEDLINE]
Free Article
19.

miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.

Cai J, Fang L, Huang Y, Li R, Yuan J, Yang Y, Zhu X, Chen B, Wu J, Li M.

Cancer Res. 2013 Sep 1;73(17):5402-15. doi: 10.1158/0008-5472.CAN-13-0297. Epub 2013 Jul 15.

PMID:
23856247
[PubMed - indexed for MEDLINE]
20.

miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.

Hu J, Fang Y, Cao Y, Qin R, Chen Q.

Dig Dis Sci. 2014 Feb;59(2):336-45. doi: 10.1007/s10620-013-2923-3. Epub 2013 Nov 19.

PMID:
24248414
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk